Literature DB >> 8539540

Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern.

K Persson1, A Månsson, E Jönsson, E Nordenfelt.   

Abstract

Antibodies to herpes simplex virus type 2 (HSV-2) and Chlamydia trachomatis (Ct) were determined in sera from pregnant women from 1970 and at intervals up to 1993. The trends for HSV-2 and Ct infections were deduced from the observed antibody rates in different age groups during the observation period. Total antibody rates for HSV-2 tended to decline toward the end of the period when age-matched groups were compared, while the Ct antibody rates peaked in 1979 and then declined gradually. Age-specific antibody rates showed declining frequencies in women younger than 20 years for both HSV-2 and Ct over the study period. Women 35 years of age and older in the early 1990s had significantly higher antibody rates than younger women at that time or than women of similar age in the early 1970s. This group of slightly older women with high antibody rates in the 1990s were 15-20 years of age in 1970 when a high antibody frequency was noted in this age group. High antibody rates against both HSV-2 and Ct in older pregnant women in the early 1990s may thus reflect a high incidence of these infections around 1970. The declining rates of antibodies in the youngest women would suggest a declining incidence of primary infections in this group.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539540     DOI: 10.3109/00365549509019008

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  14 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

Review 2.  Genital herpes simplex virus infection in the adolescent: special considerations for management.

Authors:  Lawrence R Stanberry; Susan L Rosenthal
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Neonatal herpes prevention: a minor public health problem in some communities.

Authors:  A Mindel; J Taylor; R L Tideman; C Seifert; G Berry; K Wagner; J Page; C Marks; B Trudinger; A Cunningham
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

Review 4.  Recent trends in the epidemiology of sexually transmitted infections in the European Union.

Authors:  K A Fenton; C M Lowndes
Journal:  Sex Transm Infect       Date:  2004-08       Impact factor: 3.519

Review 5.  Ethics of screening for asymptomatic herpes virus type 2 infection.

Authors:  Ingela Krantz; Gun-Britt Löwhagen; Beth Maina Ahlberg; Tore Nilstun
Journal:  BMJ       Date:  2004-09-11

6.  Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy.

Authors:  M Arvaja; M Lehtinen; P Koskela; M Lappalainen; J Paavonen; T Vesikari
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

7.  STAT4 regulates antiviral gamma interferon responses and recurrent disease during herpes simplex virus 2 infection.

Authors:  Alexandra Svensson; Petra Tunbäck; Inger Nordström; Andrey Shestakov; Leonid Padyukov; Kristina Eriksson
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

8.  Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland.

Authors:  J S Smith; M Rosinska; A Trzcinska; J M Pimenta; B Litwinska; J Siennicka
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

9.  Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada.

Authors:  Michelle Howard; John W Sellors; Dan Jang; Noah J Robinson; Margaret Fearon; Janusz Kaczorowski; Max Chernesky
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies.

Authors:  Minako Ikoma; Jan-Ake Liljeqvist; Jan Groen; Koen L Glazenburg; T Hauw The; Sytske Welling-Wester
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.